Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.

@article{Tsai2012ValueAL,
  title={Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.},
  author={Tzu-hsien Tsai and Pei-Hsun Sung and Li-Teh Chang and Cheuk-Kwan Sun and Kuo-Ho Yeh and Sheng-ying Chung and Sarah Tze Chuen Chua and Yung-Lung Chen and C. -Y. Wu and Hsuen-Wen Chang and Sheung-fat Ko and Hon-Kan Yip},
  journal={Journal of atherosclerosis and thrombosis},
  year={2012},
  volume={19 12},
  pages={
          1073-82
        }
}
AIM This study investigated the impact of the circulating galectin-3 level on the 30-day prognostic outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). METHODS From May 2009 to March 2011, blood samples for assessment of the circulating galectin-3 level were collected from 196 consecutive STEMI patients treated by primary PCI and from 30 healthy volunteers. RESULTS The galectin-3 level was determined using… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Galectin-3 in acute coronary syndrome.

  • Clinical biochemistry
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)

  • International journal of molecular medicine
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND